Consequently, FADS2 knockdown plasmids were transfected into 5637 and BIU‐87 cells to establish bladder cancer cells with reduced FADS2 expression, and the transfection efficiency was confirmed (Figure 3B, S1B). This evidence concerns the gene FADS2 and urinary bladder carcinoma.